Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Injections × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 17 Myelodysplastic Syndromes 6 Leukemia, Myelomonocytic, Chronic 5 Myeloproliferative Disorders 3 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Leukemia, Monocytic, Acute 2 Advanced Solid Tumour 2 Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Strabismus 1 Solid Tumor 1 Sarcoma 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Non-Squamous Non-small Cell Lung Cancer 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Sclerosis 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia, Basophilic, Acute 1 Idiopathic Pulmonary Fibrosis 1

Interventions

trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 dabrafenib 1 Whole-Body Irradiation 1 Tacrolimus 1 Peripheral Blood Stem Cell Transplantation 1 Pemetrexed 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Immunotherapy 1 Gemcitabine 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Busulfan 1 Bone Marrow Transplantation 1 Biopsy 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡